Point72 Europe »

Ptc Therapeutics I shares owned by Point72 Europe

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by Point72 Europe from 13F filings

Historical chart of Point72 Europe investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by Point72 Europe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by Point72 Europe

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.8M 62k 61.37

More positions owned by Point72 Europe

Strategy Cl A New (MSTR)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Capital One Financial (COF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Key (KEY)
Charles Schwab Corporation (SCHW)
TPG Com Cl A (TPG)
WESCO International (WCC)
Bank of America Corporation (BAC)
Regeneron Pharmaceuticals (REGN)
Suncor Energy (SU)
Linde SHS (LIN)

View all positions for Point72 Europe

Top funds holding Ptc Therapeutics I

Vanguard Group
Rtw Investments
BlackRock
Wellington Management Company
Henderson Group
Armistice Capital
Toronto-Dominion Bank
State Street Corporation
D. E. Shaw & Co
Geode Capital Management
Citadel Advisors
FMR
Leucadia National Corporation
Tang Capital Management
Pictet Asset Management Holding SA

View all funds holding Ptc Therapeutics I